Pharmanutra Past Earnings Performance
Past criteria checks 6/6
Pharmanutra has been growing earnings at an average annual rate of 5.9%, while the Personal Products industry saw earnings growing at 3.8% annually. Revenues have been growing at an average rate of 16.7% per year. Pharmanutra's return on equity is 27.6%, and it has net margins of 14.3%.
Key information
5.9%
Earnings growth rate
3.8%
EPS growth rate
| Personal Products Industry Growth | 8.7% |
| Revenue growth rate | 16.7% |
| Return on equity | 27.6% |
| Net Margin | 14.3% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Pharmanutra makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 114 | 16 | 13 | 0 |
| 30 Jun 24 | 108 | 14 | 24 | 0 |
| 31 Mar 24 | 101 | 11 | 23 | 0 |
| 31 Dec 23 | 101 | 13 | 23 | 0 |
| 30 Sep 23 | 95 | 12 | 21 | 0 |
| 30 Jun 23 | 93 | 14 | 20 | 0 |
| 31 Mar 23 | 88 | 16 | 18 | 0 |
| 31 Dec 22 | 83 | 15 | 17 | 0 |
| 30 Sep 22 | 79 | 16 | 15 | 0 |
| 30 Jun 22 | 76 | 15 | 14 | 0 |
| 31 Mar 22 | 73 | 15 | 13 | 0 |
| 31 Dec 21 | 68 | 14 | 12 | 0 |
| 30 Sep 21 | 65 | 14 | 12 | 0 |
| 30 Jun 21 | 60 | 11 | 11 | 0 |
| 31 Mar 21 | 57 | 14 | 10 | 0 |
| 31 Dec 20 | 57 | 14 | 10 | 0 |
| 30 Sep 20 | 58 | 14 | 10 | 0 |
| 30 Jun 20 | 58 | 14 | 10 | 0 |
| 31 Mar 20 | 55 | 9 | 10 | 0 |
| 31 Dec 19 | 54 | 8 | 9 | 0 |
| 30 Sep 19 | 49 | 8 | 8 | 0 |
| 30 Jun 19 | 50 | 9 | 7 | 0 |
| 31 Mar 19 | 48 | 9 | 8 | 0 |
| 31 Dec 18 | 47 | 9 | 8 | 0 |
| 30 Sep 18 | 44 | 8 | 8 | 0 |
| 30 Jun 18 | 41 | 7 | 7 | 0 |
| 31 Mar 18 | 40 | 6 | 7 | 0 |
| 31 Dec 17 | 38 | 6 | 6 | 0 |
| 30 Sep 17 | 37 | 5 | 6 | 0 |
| 30 Jun 17 | 35 | 5 | 5 | 0 |
| 31 Mar 17 | 34 | 4 | 5 | 0 |
| 31 Dec 16 | 33 | 4 | 5 | 0 |
| 31 Dec 15 | 26 | 3 | 5 | 0 |
Quality Earnings: 761 has high quality earnings.
Growing Profit Margin: 761's current net profit margins (14.3%) are higher than last year (12.6%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 761's earnings have grown by 5.9% per year over the past 5 years.
Accelerating Growth: 761's earnings growth over the past year (36.3%) exceeds its 5-year average (5.9% per year).
Earnings vs Industry: 761 earnings growth over the past year (36.3%) exceeded the Personal Products industry 10.8%.
Return on Equity
High ROE: 761's Return on Equity (27.6%) is considered high.